Overview
- The Global X Uranium ETF has risen 65% over the past year, underscoring renewed investor interest in nuclear energy.
- Shares of upstart reactor developers Oklo and Nano Nuclear are up 278% and 21% respectively, after sharp swings.
- Both companies remain pre-revenue with no commercial products, and their paths to licensing and deployment are lengthy.
- Oklo does not expect its first Aurora reactor to start operating until 2027 or 2028, while commercial deployment for Nano Nuclear is described as more likely in the 2030s.
- Motley Fool’s analysis points to Constellation Energy, the largest U.S. nuclear operator with major deals, as a lower-risk way to gain nuclear exposure.